[A Case of Multiple Liver Metastases from Breast Cancer Treated with Sacituzumab Govitecan Using a Scalp Cooling System].
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
surgery for bilateral breast cancer in 2021
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
The patient did not require a wig, and the scalp cooling system demonstrated a favorable hair preservation effect. Further case accumulation is necessary to evaluate the hair loss prevention effect of the scalp cooling system during sacituzumab govitecan administration.
The patient was a 51-year-old woman who underwent surgery for bilateral breast cancer in 2021.
APA
Terui T, Hasegawa S, et al. (2025). [A Case of Multiple Liver Metastases from Breast Cancer Treated with Sacituzumab Govitecan Using a Scalp Cooling System].. Gan to kagaku ryoho. Cancer & chemotherapy, 52(13), 1386-1388.
MLA
Terui T, et al.. "[A Case of Multiple Liver Metastases from Breast Cancer Treated with Sacituzumab Govitecan Using a Scalp Cooling System].." Gan to kagaku ryoho. Cancer & chemotherapy, vol. 52, no. 13, 2025, pp. 1386-1388.
PMID
41546357 ↗
Abstract 한글 요약
The patient was a 51-year-old woman who underwent surgery for bilateral breast cancer in 2021. In 2023, 2 years after surgery, multiple liver metastases were detected. Although she was treated with paclitaxel(PTX)plus bevacizumab(Bev), followed by pembrolizumab(Pemb)in combination with carboplatin(CBDCA)and gemcitabine(GEM), the liver metastases showed progressive disease. Sacituzumab govitecan was initiated as a third-line therapy in December 2024. At that time, a scalp cooling system was used, resulting in hair loss equivalent to CTCAE Grade 1. The patient did not require a wig, and the scalp cooling system demonstrated a favorable hair preservation effect. Further case accumulation is necessary to evaluate the hair loss prevention effect of the scalp cooling system during sacituzumab govitecan administration.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.